Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyPnotiKs: Best Hypnotic Drug Choice for Rapid Sequence Induction
NCT06733129Phase 3Recruiting
- Sponsor
- CHU de Nantes
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine, propofol injection (veterinary) in rapid sequence induction (RSI), sponsored by CHU de Nantes. Started Apr 2025; status: recruiting.
02
Drugs
ketaminepropofol injection (veterinary)
03
Conditions
rapid sequence induction (RSI)
Beyond the preview
Go deeper on NCT06733129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06733129.